科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/11/09 | 3,305 | 3,324 | 3,218 | 3,251 | -82 | -2.5% | 299,300 |
| 2023/11/08 | 3,336 | 3,377 | 3,313 | 3,333 | +22 | +0.7% | 314,200 |
| 2023/11/07 | 3,338 | 3,352 | 3,311 | 3,311 | -2 | -0.1% | 107,200 |
| 2023/11/06 | 3,355 | 3,355 | 3,312 | 3,313 | -37 | -1.1% | 113,600 |
| 2023/11/02 | 3,350 | 3,352 | 3,333 | 3,350 | ±0 | ±0% | 78,200 |
| 2023/11/01 | 3,361 | 3,369 | 3,336 | 3,350 | +17 | +0.5% | 158,100 |
| 2023/10/31 | 3,289 | 3,340 | 3,289 | 3,333 | +51 | +1.6% | 109,300 |
| 2023/10/30 | 3,311 | 3,322 | 3,278 | 3,282 | -66 | -2% | 130,600 |
| 2023/10/27 | 3,329 | 3,349 | 3,308 | 3,348 | +30 | +0.9% | 62,600 |
| 2023/10/26 | 3,343 | 3,354 | 3,297 | 3,318 | -16 | -0.5% | 100,800 |
| 2023/10/25 | 3,374 | 3,374 | 3,334 | 3,334 | -19 | -0.6% | 77,400 |
| 2023/10/24 | 3,333 | 3,363 | 3,301 | 3,353 | -8 | -0.2% | 80,300 |
| 2023/10/23 | 3,348 | 3,375 | 3,344 | 3,361 | +17 | +0.5% | 90,400 |
| 2023/10/20 | 3,327 | 3,357 | 3,313 | 3,344 | +17 | +0.5% | 88,200 |
| 2023/10/19 | 3,302 | 3,348 | 3,302 | 3,327 | -13 | -0.4% | 70,900 |
| 2023/10/18 | 3,328 | 3,348 | 3,300 | 3,340 | +22 | +0.7% | 102,700 |
| 2023/10/17 | 3,333 | 3,344 | 3,299 | 3,318 | -4 | -0.1% | 169,200 |
| 2023/10/16 | 3,346 | 3,369 | 3,312 | 3,322 | -24 | -0.7% | 180,400 |
| 2023/10/13 | 3,446 | 3,447 | 3,346 | 3,346 | -120 | -3.5% | 272,700 |
| 2023/10/12 | 3,460 | 3,484 | 3,450 | 3,466 | +2 | +0.1% | 138,100 |
| 2023/10/11 | 3,470 | 3,473 | 3,448 | 3,464 | -7 | -0.2% | 127,300 |
| 2023/10/10 | 3,471 | 3,482 | 3,465 | 3,471 | -2 | -0.1% | 147,500 |
| 2023/10/06 | 3,461 | 3,505 | 3,460 | 3,473 | +23 | +0.7% | 155,000 |
| 2023/10/05 | 3,455 | 3,477 | 3,437 | 3,450 | -23 | -0.7% | 226,900 |
| 2023/10/04 | 3,430 | 3,488 | 3,409 | 3,473 | +15 | +0.4% | 211,200 |
| 2023/10/03 | 3,470 | 3,480 | 3,432 | 3,458 | -12 | -0.3% | 208,600 |
| 2023/10/02 | 3,516 | 3,524 | 3,470 | 3,470 | -30 | -0.9% | 248,600 |
| 2023/09/29 | 3,515 | 3,524 | 3,492 | 3,500 | -23 | -0.7% | 234,900 |
| 2023/09/28 | 3,500 | 3,551 | 3,491 | 3,523 | -109 | -3% | 197,500 |
| 2023/09/27 | 3,591 | 3,633 | 3,570 | 3,632 | +30 | +0.8% | 271,400 |
| 2023/09/26 | 3,598 | 3,622 | 3,575 | 3,602 | +4 | +0.1% | 198,600 |
| 2023/09/25 | 3,575 | 3,610 | 3,570 | 3,598 | +30 | +0.8% | 163,500 |
| 2023/09/22 | 3,575 | 3,585 | 3,561 | 3,568 | -21 | -0.6% | 186,500 |
| 2023/09/21 | 3,617 | 3,625 | 3,582 | 3,589 | -17 | -0.5% | 159,100 |
| 2023/09/20 | 3,614 | 3,628 | 3,600 | 3,606 | -10 | -0.3% | 189,600 |
| 2023/09/19 | 3,647 | 3,654 | 3,602 | 3,616 | -21 | -0.6% | 202,600 |
| 2023/09/15 | 3,569 | 3,648 | 3,569 | 3,637 | -2 | -0.1% | 699,500 |
| 2023/09/14 | 3,600 | 3,640 | 3,573 | 3,639 | +47 | +1.3% | 236,200 |
| 2023/09/13 | 3,602 | 3,608 | 3,557 | 3,592 | -4 | -0.1% | 196,300 |
| 2023/09/12 | 3,561 | 3,614 | 3,557 | 3,596 | +45 | +1.3% | 170,400 |
| 2023/09/11 | 3,560 | 3,574 | 3,542 | 3,551 | -18 | -0.5% | 150,600 |
| 2023/09/08 | 3,551 | 3,579 | 3,543 | 3,569 | +18 | +0.5% | 156,600 |
| 2023/09/07 | 3,560 | 3,565 | 3,541 | 3,551 | -11 | -0.3% | 168,300 |
| 2023/09/06 | 3,565 | 3,565 | 3,533 | 3,562 | +2 | +0.1% | 180,900 |
| 2023/09/05 | 3,577 | 3,577 | 3,546 | 3,560 | -17 | -0.5% | 148,400 |
| 2023/09/04 | 3,575 | 3,585 | 3,551 | 3,577 | +4 | +0.1% | 109,600 |
| 2023/09/01 | 3,560 | 3,586 | 3,535 | 3,573 | -7 | -0.2% | 162,300 |
| 2023/08/31 | 3,573 | 3,602 | 3,544 | 3,580 | +4 | +0.1% | 162,200 |
| 2023/08/30 | 3,548 | 3,591 | 3,543 | 3,576 | +23 | +0.6% | 427,300 |
| 2023/08/29 | 3,550 | 3,553 | 3,515 | 3,553 | -1 | ±0% | 256,700 |
401～
450
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 379,100円 | -6.4% | -71.8% | 5.01% | 42.34倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サンバイオ | 233,200円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ジーエヌアイ | 330,000円 | +21.7% | +999.9% | 0.00% | 13.83倍 | 4.76倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 299,700円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
